Atossa Therapeutics
ATOS
#9315
Rank
S$0.12 B
Marketcap
S$0.94
Share price
3.82%
Change (1 day)
-27.70%
Change (1 year)

Atossa Therapeutics (ATOS) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : S$10.63 Million

According to Atossa Therapeutics's latest financial reports the company's total liabilities are S$10.63 Million. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Atossa Therapeutics - Total liabilities on balance sheet (from 2010 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31S$6.75 M-2.37%
2023-12-31S$6.91 M-7.36%
2022-12-31S$7.46 M76.63%
2021-12-31S$4.22 M-79.62%
2020-12-31S$20.73 M1052.87%
2019-12-31S$1.79 M-54.85%
2018-12-31S$3.98 M143.01%
2017-12-31S$1.63 M8.13%
2016-12-31S$1.51 M-57.17%
2015-12-31S$3.53 M18.19%
2014-12-31S$2.99 M67.91%
2013-12-31S$1.78 M-11.66%
2012-12-31S$2.01 M3.07%
2011-12-31S$1.95 M75.38%
2010-12-31S$1.11 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Johnson & Johnson
JNJ
S$146.74 B 1,380,313.37%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
S$12.34 B 115,992.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Quest Diagnostics
DGX
S$11.40 B 107,146.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Enzo Biochem
ENZB
S$26 M 144.60%๐Ÿ‡บ๐Ÿ‡ธ USA
NeoGenomics
NEO
S$0.69 B 6,422.67%๐Ÿ‡บ๐Ÿ‡ธ USA